Search Results - "Reid, Justin H."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management by Homan, Morgan J., Reid, Justin H., Nachar, Victoria R., Benitez, Lydia L., Brown, Anna M., Kraft, Shawna, Hough, Shannon, Christen, Catherine, Frame, David, McDevitt, Rachel L.

    Published in Supportive care in cancer (01-11-2021)
    “…Introduction Nausea, vomiting, constipation, and diarrhea are common cancer and cancer therapy adverse effects. Pharmacists are uniquely positioned to optimize…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma by Reid, Justin H., Marini, Bernard L., Nachar, Victoria R., Brown, Anna M., Devata, Sumana, Perissinotti, Anthony J.

    Published in Critical reviews in oncology/hematology (01-04-2020)
    “…[Display omitted] Advanced classical Hodgkin lymphoma (cHL) is a rare lymphoid disease characterized by the presence of Hodgkin and Reed-Sternberg (HRS) cells…”
    Get full text
    Journal Article
  5. 5

    Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis by Reid, Justin H., Perissinotti, Anthony J., Benitez, Lydia, Bixby, Dale L., Burke, Patrick, Pettit, Kristen, Marini, Bernard L.

    Published in Leukemia & lymphoma (20-03-2020)
    “…Central nervous system (CNS) relapse in acute myeloid leukemia (AML) confers a poor prognosis. Despite the identification of risk factors for CNS relapse (e.g…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts by Reid, Justin H., Perissinotti, Anthony J., Benitez, Lydia L., Boyer, Daniel, Lee, Winston, Burke, Patrick W., Pettit, Kristen, Bixby, Dale L., Marini, Bernard L.

    Published in Leukemia research (01-04-2021)
    “…•Acute leukemia with mixed-phenotype blasts is associated with poor outcomes.•AML-based regimens, ALL-based regimens, and hybrid AML/ALL-based regimens have…”
    Get full text
    Journal Article
  8. 8

    Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia by Reid, Justin H., Marini, Bernard L., Benitez, Lydia L., Pettit, Kristen, Bixby, Dale L., Burke, Patrick, Perissinotti, Anthony J.

    Published in Clinical lymphoma, myeloma and leukemia (01-06-2021)
    “…Relapsed/refractory acute myeloid leukemia (AML) confers a poor prognosis, and there is no single standard of care first-line salvage regimen. FLAG…”
    Get full text
    Journal Article
  9. 9

    Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura by Reid, Justin H, Durant, Karin M, Chen, Sheh-Li, Perissinotti, Anthony J, King, Richard, Khoriaty, Rami, Marini, Bernard L

    Published in Journal of Oncology Pharmacy Practice (01-10-2020)
    “…Acquired thrombotic thrombocytopenic purpura is a rare blood disorder with a high early mortality rate, if untreated. Standard of care plasma exchange and…”
    Get full text
    Book Review Journal Article
  10. 10
  11. 11